Hypoprothrombinaemia associated with use of cephamandole.
We report 4 cases in which the use of cephamandole was associated with coagulopathy. All 4 patients had renal impairment, but no other known predisposing factors. It is recommended that the coagulation profile be monitored during administration of cephamandole, especially when there is a background of renal impairment.
O'Donnell
D
D
Department of General Medicine, Fremantle Hospital, Western Australia.
D000328:Adult; D000368:Aged; D002435:Cefamandole / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged
D002435:Cefamandole